EEburyraised$700M·Growth|SStarcloudraised$200M·Growth|FFunraised$72M·Series A|SStandard Intelligenceraised$75M·Series A|NNetomiraised$110M·Series C|PParallel Web Systemsraised$100M·Series B|RRogoraised$160M·Series D|HHightouchraised$150M·Series D|TTrue Anomalyraised$650M·Series D|SSaronicraised$1.75B·Series D|AAvocaraised$125M·Series B|SSiFiveraised$400M·Series G|SSidewinder Therapeuticsraised$137M·Series B|HHermeusraised$350M·Series C|WWHOOPraised$575M·Series G|
OrchidOR
OR

Orchid

Helping couples have healthy babies

Visit
SAASSeedEst. 202011–50 employeesSan Francisco, United States

Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes.

Founders

View Open Roles at Orchid